Kinnate Biopharma Inc.
NASDAQ:KNTE
2.65 (USD) • At close April 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities: | ||||||
| Net Income
| -112.649 | -116.271 | -89.763 | -35.761 | -11.969 | -7.63 |
| Depreciation & Amortization
| 0.799 | 0.604 | 0.123 | 0.083 | 0 | 0 |
| Deferred Income Tax
| -26.589 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 19.918 | 19.582 | 15.016 | 2.478 | 0.039 | 0.039 |
| Change In Working Capital
| -3.704 | 6.369 | 1.624 | 3.014 | 1.404 | -0.611 |
| Accounts Receivables
| 0 | 0 | 0 | 0.973 | -0.049 | 0 |
| Inventory
| 0 | 0 | 0 | -0.973 | 0 | 0 |
| Accounts Payables
| -5.073 | 4.195 | 4.677 | 5.359 | 1.478 | 0 |
| Other Working Capital
| 1.369 | 2.174 | -3.053 | -2.345 | -0.025 | -0.611 |
| Other Non Cash Items
| 22.182 | 0.682 | 1.935 | 0.005 | -1.39 | 0 |
| Operating Cash Flow
| -100.043 | -89.034 | -71.065 | -30.181 | -10.526 | -8.202 |
| Investing Activities: | ||||||
| Investments In Property Plant And Equipment
| 0 | -2.719 | -0.769 | -0.297 | 0 | 0 |
| Acquisitions Net
| -9.133 | 0.004 | 34.853 | 0 | 0 | 0 |
| Purchases Of Investments
| -154.719 | -176.528 | -247.142 | -31.412 | 0 | 0 |
| Sales Maturities Of Investments
| 264.588 | 172.417 | 67.337 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -0.004 | -34.853 | -0.031 | 0 | 0 |
| Investing Cash Flow
| 100.736 | -6.83 | -180.574 | -31.709 | 0 | 0 |
| Financing Activities: | ||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 1.325 | 0 | 0 | 253.314 | 79.98 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | -0.017 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -9.133 | 0.001 | 0.036 | 97.602 | 0.08 | 15.201 |
| Financing Cash Flow
| 1.325 | 0.001 | 0.036 | 350.899 | 79.98 | 15.201 |
| Other Information: | ||||||
| Effect Of Forex Changes On Cash
| -0.006 | 0.001 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 2.012 | -94.703 | -215.402 | 289.009 | 69.454 | 6.999 |
| Cash At End Of Period
| 56.998 | 55.357 | 150.06 | 365.462 | 76.453 | 6.999 |